DE69724780D1 - Polysaccharidschwämme für zellkultur und transplantation - Google Patents

Polysaccharidschwämme für zellkultur und transplantation

Info

Publication number
DE69724780D1
DE69724780D1 DE69724780T DE69724780T DE69724780D1 DE 69724780 D1 DE69724780 D1 DE 69724780D1 DE 69724780 T DE69724780 T DE 69724780T DE 69724780 T DE69724780 T DE 69724780T DE 69724780 D1 DE69724780 D1 DE 69724780D1
Authority
DE
Germany
Prior art keywords
spones
polysaccharid
transplantation
cell culture
mum
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69724780T
Other languages
English (en)
Other versions
DE69724780T2 (de
Inventor
Lilia Shapiro
Rachel Glicklis
Smadar Cohen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ben Gurion University of the Negev Research and Development Authority Ltd
Original Assignee
Ben Gurion University of the Negev Research and Development Authority Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ben Gurion University of the Negev Research and Development Authority Ltd filed Critical Ben Gurion University of the Negev Research and Development Authority Ltd
Publication of DE69724780D1 publication Critical patent/DE69724780D1/de
Application granted granted Critical
Publication of DE69724780T2 publication Critical patent/DE69724780T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/10—Hair or skin implants
    • A61F2/105—Skin implants, e.g. artificial skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/20—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/56—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/60—Materials for use in artificial skin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J9/00—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof
    • C08J9/26—Working-up of macromolecular substances to porous or cellular articles or materials; After-treatment thereof by elimination of a solid phase from a macromolecular composition or article, e.g. leaching out
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2210/0004—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof bioabsorbable
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2250/00—Special features of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
    • A61F2250/0058—Additional features; Implant or prostheses properties not otherwise provided for
    • A61F2250/0067—Means for introducing or releasing pharmaceutical products into the body
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08J—WORKING-UP; GENERAL PROCESSES OF COMPOUNDING; AFTER-TREATMENT NOT COVERED BY SUBCLASSES C08B, C08C, C08F, C08G or C08H
    • C08J2305/00—Characterised by the use of polysaccharides or of their derivatives not provided for in groups C08J2301/00 or C08J2303/00
    • C08J2305/02—Dextran; Derivatives thereof
DE69724780T 1996-05-22 1997-05-21 Polysaccharidschwämme für zellkultur und transplantation Expired - Lifetime DE69724780T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL11837696 1996-05-22
IL11837696A IL118376A0 (en) 1996-05-22 1996-05-22 Polysaccharide sponges for cell culture and transplantation
PCT/IL1997/000161 WO1997044070A1 (en) 1996-05-22 1997-05-21 Polysaccharide sponges for cell culture and transplantation

Publications (2)

Publication Number Publication Date
DE69724780D1 true DE69724780D1 (de) 2003-10-16
DE69724780T2 DE69724780T2 (de) 2004-07-15

Family

ID=11068894

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69724780T Expired - Lifetime DE69724780T2 (de) 1996-05-22 1997-05-21 Polysaccharidschwämme für zellkultur und transplantation

Country Status (12)

Country Link
US (3) US6425918B1 (de)
EP (1) EP0901384B1 (de)
JP (1) JP2000512666A (de)
AT (1) ATE249251T1 (de)
AU (1) AU714647B2 (de)
CA (1) CA2256327C (de)
DE (1) DE69724780T2 (de)
DK (1) DK0901384T3 (de)
ES (1) ES2206707T3 (de)
IL (1) IL118376A0 (de)
PT (1) PT901384E (de)
WO (1) WO1997044070A1 (de)

Families Citing this family (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2318577B (en) * 1996-10-28 2000-02-02 Johnson & Johnson Medical Solvent dried polysaccharide sponges
WO1999058656A2 (en) * 1998-05-13 1999-11-18 The Regents Of The University Of Michigan Sustained dna delivery from structural matrices
IL124957A0 (en) * 1998-06-16 1999-01-26 Univ Ben Gurion Active ingredient delivery systems and devices based on porous matrices
KR100298846B1 (ko) * 1998-09-24 2003-10-22 한국원자력연구소 중화키토산스폰지또는중화키토산/콜라겐혼합스폰지를이용한인공진피
DK1229940T3 (da) * 1999-11-15 2014-08-18 Piramal Healthcare Canada Ltd Temperaturstyret og ph-afhængig selvgelerende, vandig biopolymeropløsning
DE19957388A1 (de) * 1999-11-24 2001-06-13 Michael Sittinger Chondroinduktive und implantierbare Substrate zur Knorpelheilung und -protektion
SG149679A1 (en) * 2000-06-29 2009-02-27 Biosyntech Canada Inc Composition and method for the repair and regeneration of cartilage and other tissues
US7214371B1 (en) 2000-09-01 2007-05-08 Ben-Gurion University Of The Negev Research & Development Authority Tissue engineered biografts for repair of damaged myocardium
EP1369441A4 (de) * 2001-01-31 2004-12-08 Seikagaku Kogyo Co Ltd Schwamm aus vernetztem polysaccharid
AU2002229823B2 (en) * 2001-04-04 2007-02-15 Delsitech Oy Biodegradable carrier and method for preparation thereof
CN1289063C (zh) * 2001-05-11 2006-12-13 奥索-麦克尼尔药品公司 用于动物的免疫调节装置
JP2003052395A (ja) * 2001-08-09 2003-02-25 Japan Tissue Engineering:Kk 移植適正判定方法
TWI230619B (en) * 2001-08-16 2005-04-11 Ind Tech Res Inst Method of crosslinking of porous biodegradable polymers
JP3770555B2 (ja) * 2001-10-25 2006-04-26 独立行政法人科学技術振興機構 複合生体材料
WO2003053216A2 (en) * 2001-12-06 2003-07-03 University Of Washington Biodegradable, porous structures useful for growing living tissue, and methods of manufacture
US20040029266A1 (en) * 2002-08-09 2004-02-12 Emilio Barbera-Guillem Cell and tissue culture device
US20040063206A1 (en) * 2002-09-30 2004-04-01 Rowley Jon A. Programmable scaffold and method for making and using the same
US20040147016A1 (en) * 2002-09-30 2004-07-29 Rowley Jonathan A. Programmable scaffold and methods for making and using the same
KR100539371B1 (ko) * 2002-10-21 2005-12-27 메디칸(주) 인체 세포의 체외배양 방법
US20040126405A1 (en) * 2002-12-30 2004-07-01 Scimed Life Systems, Inc. Engineered scaffolds for promoting growth of cells
EP1592373B1 (de) * 2003-01-30 2013-04-24 ProChon Biotech Ltd. Gefriergetrocknete fibrinmatrizen und herstellungsverfahren dafür
KR100984184B1 (ko) * 2003-03-18 2010-09-28 에스케이케미칼주식회사 알긴산 스폰지 및 그의 제조방법
WO2004087797A1 (en) * 2003-04-03 2004-10-14 Corporation De L'ecole Polytechnique De Montreal Microporous articles comprising biodegradable medical polymers, method of preparation thereof and method of use thereof
KR101180896B1 (ko) * 2003-05-05 2012-09-07 벤-구리온 유니버시티 오브 더 네게브 리서치 앤드 디벨럽먼트 어쏘러티 주사용 가교결합된 폴리머 제제 및 그의 용도
DE10323794A1 (de) * 2003-05-23 2004-12-09 Dr. Suwelack Skin & Health Care Ag Verfahren zur Herstellung von Alginat-haltigen porösen Formkörpern
JP2005046538A (ja) * 2003-07-31 2005-02-24 Jms Co Ltd 医療用多孔質体およびその製造方法
CN100563725C (zh) * 2003-09-08 2009-12-02 Fmc生物聚合物联合股份有限公司 胶凝生物聚合物基泡沫
JP2005080927A (ja) * 2003-09-09 2005-03-31 Jms Co Ltd 医療用多孔質体の製造方法
EP1666503B1 (de) * 2003-09-12 2010-05-05 Seikagaku Corporation Polysaccharid-pseudoschwamm
US8073538B2 (en) * 2003-11-13 2011-12-06 Cardio Polymers, Inc. Treatment of cardiac arrhythmia by modification of neuronal signaling through fat pads of the heart
WO2005049111A2 (en) * 2003-11-13 2005-06-02 Symphony Medical, Inc. Control of cardiac arrhythmias by modification of neuronal conduction within fat pads of the heart
WO2005066337A2 (en) * 2004-01-09 2005-07-21 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compounds, pharmaceutical compositions and therapeutic methods of preventing and treating diseases and disorders associated with amyloid fibril formation
US20050272153A1 (en) 2004-01-27 2005-12-08 Zou Xuenong Bone tissue engineering by ex vivo stem cells ongrowth into three-dimensional trabecular metal
US7687619B2 (en) * 2004-02-05 2010-03-30 Millipore Corporation Room temperature stable agarose solutions
WO2005078028A1 (en) * 2004-02-05 2005-08-25 Millipore Corporation Method of forming polysaccharide structures
JP4607522B2 (ja) * 2004-08-31 2011-01-05 焼津水産化学工業株式会社 高分子複合体の製造方法及び該製造方法によって得られる高分子複合体、並びに該高分子複合体を用いた動物細胞の培養方法
CA2583373C (en) * 2004-10-12 2013-09-03 Fmc Biopolymer As Self-gelling alginate systems and uses thereof
US7514256B2 (en) 2005-02-11 2009-04-07 Emilio Barbera-Guillem Bioreactor for selectively controlling the molecular diffusion between fluids
US9427496B2 (en) 2005-02-18 2016-08-30 Drexel University Method for creating an internal transport system within tissue scaffolds using computer-aided tissue engineering
US20060239956A1 (en) * 2005-04-26 2006-10-26 Lulu Henson Preparation and use of hydrogels
US20060292690A1 (en) * 2005-06-22 2006-12-28 Cesco Bioengineering Co., Ltd. Method of making cell growth surface
AU2006292224B2 (en) 2005-09-19 2013-08-01 Histogenics Corporation Cell-support matrix and a method for preparation thereof
US9132208B2 (en) * 2008-08-07 2015-09-15 Lifenet Health Composition for a tissue repair implant and methods of making the same
US9005646B2 (en) 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
EP2347775B1 (de) 2005-12-13 2020-04-15 President and Fellows of Harvard College Gerüste zur zelltransplantation
TWI285100B (en) * 2005-12-27 2007-08-11 Ind Tech Res Inst Surface modification of polysaccharide, the modified polysaccharide, and method of culturing and recovery cells using the same
WO2007103208A2 (en) * 2006-03-01 2007-09-13 Fmc Biopolymer As Biodegradable foam
US20080124372A1 (en) 2006-06-06 2008-05-29 Hossainy Syed F A Morphology profiles for control of agent release rates from polymer matrices
US8168215B2 (en) * 2006-06-16 2012-05-01 Fmc Biopolymer As Alginate coated, collagen matrix cellular device, preparative methods, and uses thereof
EP2046288B1 (de) * 2006-07-14 2013-07-03 FMC Biopolymer AS Hydrogele mit niedermolekularen alginaten und daraus hergestellte biostrukturen
CA2662169C (en) * 2006-09-08 2018-03-20 Symphony Medical, Inc. Intramyocardial patterning for global cardiac resizing and reshaping
WO2008045506A2 (en) * 2006-10-10 2008-04-17 President And Fellows Of Harvard College Biopolymer structures
EP2120546B1 (de) * 2006-12-18 2016-09-28 Ben Gurion University Of The Negev Gerüst für die geweberegeneration oder reparatur
WO2008081463A2 (en) * 2007-01-04 2008-07-10 Hepacore Ltd. Water soluble reactive derivatives of carboxy polysaccharides and fibrinogen conjugates thereof
WO2008112170A1 (en) 2007-03-09 2008-09-18 Corning Incorporated Three dimensional gum matrices for cell culture, manufacturing methods and methods of use
US20080220526A1 (en) * 2007-03-09 2008-09-11 Ellison Adam J Gum coatings for cell culture, methods of manufacture and methods of use
EP2146667A2 (de) * 2007-04-11 2010-01-27 Henry Ford Health System Herzreparatur, grössen- und formanapassung anhand des herzvenensystems
WO2008154033A2 (en) * 2007-06-11 2008-12-18 Symphony Medical, Inc. Cardiac patterning for improving diastolic function
EP2155810A4 (de) * 2007-06-13 2013-07-03 Fmc Corp Alginatbeschichteter, polysaccharidgelhaltiger schaumverbundstoff, herstellungsverfahren und verwendungen davon
WO2009002401A2 (en) 2007-06-21 2008-12-31 President And Fellows Of Harvard College Scaffolds for cell collection or elimination
KR20100063744A (ko) * 2007-08-28 2010-06-11 에프엠씨 코포레이션 지연된 자가-겔화 알기네이트 시스템 및 이의 용도
IL187707A0 (en) * 2007-11-27 2008-11-03 Univ Ben Gurion Alginate scaffold in hepatectomy
JP5690143B2 (ja) 2008-02-13 2015-03-25 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 持続的細胞プログラミング装置
US9370558B2 (en) 2008-02-13 2016-06-21 President And Fellows Of Harvard College Controlled delivery of TLR agonists in structural polymeric devices
WO2009108760A2 (en) 2008-02-26 2009-09-03 Board Of Regents, The University Of Texas System Dendritic macroporous hydrogels prepared by crystal templating
US20090259210A1 (en) * 2008-04-10 2009-10-15 Sabbah Hani N Method, apparatus and kits for forming structural members within the cardiac venous system
AU2009240513B2 (en) * 2008-04-24 2015-03-26 Medtronic, Inc. Chitosan-containing protective composition
JP5833919B2 (ja) * 2008-04-24 2015-12-16 メドトロニック，インコーポレイテッド キトサンと酸化多糖とに基づく保護用ゲル
CA2721985C (en) * 2008-04-24 2016-06-21 Medtronic, Inc. Thiolated chitosan gel for treating mucosal tissue
WO2009132229A2 (en) 2008-04-24 2009-10-29 Medtronic, Inc. Cold ionizing radiation sterilization
EP2291524A2 (de) * 2008-04-24 2011-03-09 Medtronic, Inc Rehydratisierbare thiolierte polysaccharidpartikel und schwamm
AU2009313252A1 (en) * 2008-11-07 2011-08-18 Kuehnle Agrosystems, Inc. Preservation and composition of bioprocess algae for production of lipids, seedstock, and feed
US8735140B2 (en) * 2008-11-07 2014-05-27 Kuehnle Agrosystems, Inc. Preservation and composition of bioprocess algae for production of lipids, seedstock, and feed
US9297005B2 (en) 2009-04-13 2016-03-29 President And Fellows Of Harvard College Harnessing cell dynamics to engineer materials
CA2768552A1 (en) 2009-07-31 2011-02-03 President And Fellows Of Harvard College Programming of cells for tolerogenic therapies
TR201904204T4 (tr) * 2009-09-10 2019-04-22 Dupont Nutrition Usa Inc Eklemsiz aljinat kapsülleri.
EP2542230A4 (de) 2010-03-05 2013-08-28 Harvard College Förderung des anwachsens von skelettmuskel-stammzellen durch gleichzeitige verabreichung von vegf und igf-1
US9226524B2 (en) 2010-03-26 2016-01-05 Philip Morris Usa Inc. Biopolymer foams as filters for smoking articles
WO2011163669A2 (en) 2010-06-25 2011-12-29 President And Fellows Of Harvard College Co-delivery of stimulatory and inhibitory factors to create temporally stable and spatially restricted zones
CN107648668B (zh) 2010-10-06 2021-06-18 哈佛学院董事会 用于基于材料的细胞疗法的可注射的成孔水凝胶
WO2012048283A1 (en) 2010-10-08 2012-04-12 Board Of Regents, The University Of Texas System One-step processing of hydrogels for mechanically robust and chemically desired features
US9095558B2 (en) 2010-10-08 2015-08-04 Board Of Regents, The University Of Texas System Anti-adhesive barrier membrane using alginate and hyaluronic acid for biomedical applications
US9603894B2 (en) 2010-11-08 2017-03-28 President And Fellows Of Harvard College Materials presenting notch signaling molecules to control cell behavior
WO2012140650A2 (en) 2011-04-12 2012-10-18 Hepacore Ltd. Conjugates of carboxy polysaccharides with fibroblast growth factors and variants thereof
WO2012148684A1 (en) 2011-04-27 2012-11-01 President And Fellows Of Harvard College Cell-friendly inverse opal hydrogels for cell encapsulation, drug and protein delivery, and functional nanoparticle encapsulation
ES2685327T3 (es) 2011-04-28 2018-10-08 President And Fellows Of Harvard College Armazones tridimensionales macroscópicos preformados inyectables para administración mínimamente invasiva
US9675561B2 (en) 2011-04-28 2017-06-13 President And Fellows Of Harvard College Injectable cryogel vaccine devices and methods of use thereof
WO2012167230A1 (en) 2011-06-03 2012-12-06 President And Fellows Of Harvard College In situ antigen-generating cancer vaccine
US9765205B2 (en) 2011-08-24 2017-09-19 Algix, Llc Macrophyte-based bioplastic
WO2013031030A1 (en) 2011-09-01 2013-03-07 L'oreal Cosmetic sheet
EP3662896B1 (de) 2012-04-16 2024-02-28 President and Fellows of Harvard College Mesoporöse siliciumdioxidzusammensetzungen zur modulierung von immunreaktionen
US11565027B2 (en) 2012-12-11 2023-01-31 Board Of Regents, The University Of Texas System Hydrogel membrane for adhesion prevention
EP2938347A4 (de) * 2012-12-30 2016-08-10 Hadasit Med Res Service Verwendung von alginatzusammensetzungen zur verhütung oder verminderung von leberschäden durch hepatotoxika
US10016524B2 (en) 2013-04-11 2018-07-10 President And Fellows Of Harvard College Prefabricated alginate-drug bandages
EP3003266A2 (de) * 2013-05-29 2016-04-13 Therakine Biodelivery GmbH Hydrophile mikropartikel, wirkstofffreisetzungsmaterial, verfahren zur herstellung davon und verfahren zur freisetzung einer wirkstofffreisetzungszusammensetzung
SG11201510209SA (en) 2013-06-13 2016-01-28 Orgenesis Ltd Cell populations, methods of transdifferention and methods of use thereof
JP7348708B2 (ja) 2014-04-30 2023-09-21 プレジデント・アンド・フェロウズ・オブ・ハーバード・カレッジ 組み合わせワクチン装置および癌細胞を殺滅する方法
CN104001213B (zh) * 2014-05-07 2016-06-29 广州贝奥吉因生物科技有限公司 一种软骨组织工程用多孔支架及其制备方法
US10077420B2 (en) 2014-12-02 2018-09-18 Histogenics Corporation Cell and tissue culture container
MA41296A (fr) 2014-12-30 2017-11-07 Orgenesis Ltd Procédés de transdifférenciation et procédés d'utilisation de ceux-ci
US11786457B2 (en) 2015-01-30 2023-10-17 President And Fellows Of Harvard College Peritumoral and intratumoral materials for cancer therapy
EP3280464A4 (de) 2015-04-10 2018-09-26 President and Fellows of Harvard College Immunzelleneinfangende vorrichtungen und verfahren zur herstellung und verwendung davon
FR3039555B1 (fr) 2015-07-30 2017-08-18 Univ Toulouse Iii - Paul Sabatier Procede de preparation de matrices poreuses polymeres biocompatibles et biodegradables trimensionnelles et applications
CN105169473B (zh) * 2015-10-19 2018-06-29 东南大学 一种超细孔隙水凝胶支架及其制备方法
WO2017118979A1 (en) 2016-01-07 2017-07-13 B. G. Negev Technologies And Applications Ltd., At Ben-Gurion University Compositions and methods for generating immunotolerant responses
CN115487351A (zh) 2016-02-06 2022-12-20 哈佛学院校长同事会 重塑造血巢以重建免疫
MA45738A (fr) 2016-07-13 2019-05-22 Harvard College Échafaudages mimétiques de cellules présentant l'antigène et procédés pour les préparer et les utiliser
US10821200B2 (en) 2016-12-05 2020-11-03 Hyalo Technologies, LLC Method of sterilization of microparticles
EP3635106A4 (de) 2017-05-08 2021-01-06 Orgenesis Ltd. Transdifferenzierte zellpopulationen und verfahren zur verwendung davon
CN108853570B (zh) * 2018-07-16 2021-04-27 浦易（上海）生物技术有限公司 一种止血海绵及其制备方法
US11434460B2 (en) 2019-02-05 2022-09-06 Corning Incorporated Woven cell culture substrates, bioreactor systems using the same, and related methods
US11118151B2 (en) 2019-11-05 2021-09-14 Corning Incorporated Fixed bed bioreactor and methods of using the same
KR102396513B1 (ko) * 2019-12-30 2022-05-10 조선대학교 산학협력단 버섯의 감마-아미노부티르산 함량 증가용 조성물
WO2021146122A1 (en) * 2020-01-13 2021-07-22 The Regents Of The University Of California Devices and methods for high-stability supercooling of aqueous media and biological matter
JP7274041B2 (ja) * 2020-03-17 2023-05-15 日本たばこ産業株式会社 多孔質体の製造方法および多孔質体
CN115666492A (zh) 2020-04-30 2023-01-31 莱雅公司 护理皮肤的套装

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3653383A (en) * 1969-07-30 1972-04-04 Freeze Dry Products Algin sponge and process therefor
FR2167329A1 (en) 1972-01-13 1973-08-24 Freeze Dry Products Water-absorbent porous algin sponges - readily disposable for medical uses
JPS5571537A (en) * 1978-11-24 1980-05-29 Shin Etsu Chem Co Ltd Method of manufacturing sponge-like molded body
US4412947A (en) * 1979-09-12 1983-11-01 Seton Company Collagen sponge
JPS5658469A (en) * 1979-10-19 1981-05-21 Yoshinari Masuyama Molding method of glucomannan flour
DE2943520C2 (de) * 1979-10-27 1982-05-19 Fa. Carl Freudenberg, 6940 Weinheim Verfahren zur Herstellung von Kollagenschwamm für medizinische oder kosmetische Zwecke
US4522753A (en) * 1980-07-17 1985-06-11 Massachusetts Institute Of Technology Method for preserving porosity in porous materials
US4578067A (en) * 1982-04-12 1986-03-25 Alcon (Puerto Rico) Inc. Hemostatic-adhesive, collagen dressing for severed biological surfaces
GB2148901A (en) * 1983-10-04 1985-06-05 Johnson & Johnson Protein/polysaccharide complexes
US4515637A (en) * 1983-11-16 1985-05-07 Seton Company Collagen-thrombin compositions
US5510254A (en) * 1986-04-18 1996-04-23 Advanced Tissue Sciences, Inc. Three dimensional cell and tissue culture system
US5219361A (en) * 1988-09-16 1993-06-15 Clemson University Soft tissue implant with micron-scale surface texture to optimize anchorage
US5602026A (en) * 1988-10-14 1997-02-11 The General Hospital Corporation Culturing liver cells between two supports
AU666118B2 (en) * 1991-04-25 1996-02-01 Brown University Research Foundation Implantable biocompatible immunoisolatory vehicle for delivery of selected therapeutic products
JPH05125214A (ja) * 1991-11-01 1993-05-21 Komatsu Ltd 超高分子量ポリエチレンポーラス体およびその製造方法
GB9206509D0 (en) * 1992-03-25 1992-05-06 Jevco Ltd Heteromorphic sponges containing active agents
GB9210574D0 (en) * 1992-05-18 1992-07-01 Ca Nat Research Council Biotherapeutic cell-coated microspheres for wound/burn and prothesis implant applications
US5690996A (en) * 1992-11-02 1997-11-25 Sepragen Cross-linked cellulose sponge
US5660857A (en) * 1993-03-22 1997-08-26 Johnson & Johnson Medical Inc. Biopolymer composites
GB2281861B (en) 1993-09-21 1997-08-20 Johnson & Johnson Medical Bioabsorbable wound implant materials containing microspheres
US6176874B1 (en) * 1993-10-18 2001-01-23 Masschusetts Institute Of Technology Vascularized tissue regeneration matrices formed by solid free form fabrication techniques
DE9315877U1 (de) 1993-10-18 1994-01-05 Greenland Gmbh & Co Kg Heuwerbungsmaschine
CA2115592C (en) * 1994-02-14 1998-09-22 Kumiko Kimura Production of glucomannan sponge
US5834029A (en) * 1994-07-20 1998-11-10 Cytotherapeutics, Inc. Nerve guidance channel containing bioartificial three-dimensional hydrogel extracellular matrix derivatized with cell adhesive peptide fragment
US5891558A (en) * 1994-11-22 1999-04-06 Tissue Engineering, Inc. Biopolymer foams for use in tissue repair and reconstruction
WO1996041818A1 (en) * 1995-06-09 1996-12-27 Drohan William N Chitin hydrogels, methods of their production and use
US5965125A (en) * 1995-10-25 1999-10-12 Transkaryotic Therapies, Inc. Hybrid matrix implants and explants
EP0907721A1 (de) * 1996-05-28 1999-04-14 Brown University Research Foundation Biologisch abbaubarer träger auf basis von hyaluronan für die gewebewiederherstellung
GB2318577B (en) * 1996-10-28 2000-02-02 Johnson & Johnson Medical Solvent dried polysaccharide sponges
FI111011B (fi) * 1997-01-15 2003-05-15 Orion Yhtymae Oyj Mikro-organismien kiinteä kasvualusta, sen valmistus ja käyttö
GB9704749D0 (en) * 1997-03-07 1997-04-23 Univ London Tissue Implant
CA2285329A1 (en) * 1997-03-31 1998-10-08 The Regents Of The University Of Michigan Open pore biodegradable matrices and process for making them
US6471993B1 (en) * 1997-08-01 2002-10-29 Massachusetts Institute Of Technology Three-dimensional polymer matrices

Also Published As

Publication number Publication date
AU714647B2 (en) 2000-01-06
DE69724780T2 (de) 2004-07-15
US20030078672A1 (en) 2003-04-24
US6334968B1 (en) 2002-01-01
IL118376A0 (en) 1996-09-12
AU2711797A (en) 1997-12-09
US6793675B2 (en) 2004-09-21
DK0901384T3 (da) 2004-01-19
CA2256327A1 (en) 1997-11-27
PT901384E (pt) 2004-02-27
ATE249251T1 (de) 2003-09-15
JP2000512666A (ja) 2000-09-26
US6425918B1 (en) 2002-07-30
ES2206707T3 (es) 2004-05-16
CA2256327C (en) 2012-07-24
EP0901384A1 (de) 1999-03-17
EP0901384B1 (de) 2003-09-10
WO1997044070A1 (en) 1997-11-27

Similar Documents

Publication Publication Date Title
DE69724780D1 (de) Polysaccharidschwämme für zellkultur und transplantation
DE69736813D1 (de) Serum-freie zellkulturmedien
DE60041611D1 (de) Zusammensetzung zur Geweberegeneration
DE69635398D1 (de) Thermoformiertes Behälter für Zellcultureinsatz
BR9801144A (pt) Uso de copolímeros em bloco tendo ligados blocos de siloxano na produção de espumas de poliuretano
DE69129437D1 (de) Methode zur Anzeige von Sprachpost für zellulare Telephonsysteme
DE69121166T2 (de) Oxid-modifizierte Luftelektrodeoberfläche für elektrochemische Hochtemperaturzellen
DE69739326D1 (de) Polymerelektrolytmembranen für die verwendung in brennstoffzellen
DE60106056D1 (de) Kollagenmembran mit makromolekularer anordnung
FR2659982B1 (fr) Utilisation de substrats chromogenes dans la determination de candida.
NO982987D0 (no) Amidinoproteasehemmere
DE69115794T2 (de) Anordnung zur Zustandsumschaltung für Lautfernsprechgerät
DE69013884D1 (de) Halterung für Mobilfunktelefon.
DK0563256T3 (da) Anvendelse af værtscelle-phospholipider til inhibering af bakteriekolonisering
DE69124730D1 (de) Poröses, gasstatisches Lager
DE69111399D1 (de) Chromogenes bestimmungsverfahren für den faktor viii:ca.
WO1993023529A3 (fr) Culture stabilisee d'agregats cellulaires et procede de developpement des embryons a partir d'une souche proembryogene destine a la regeneration de la vigne
FR2657879B1 (fr) Plaque de culture cellulaire.
AR007739A1 (es) Un proceso para la preparacion de n-(r)-(2-hidroxi-2-piridina-3-il-etil) -2-(4-nitro-fenil)-acetamida
DE29604367U1 (de) Bausatz zur Erzeugung eines verdämmten, sprengtechnischen Verdämmungssystemes
KR970054728U (ko) 정화조용 미생물 배양상
NO905110D0 (no) Forbedringer i forbindelse med egenskapene til cellulosefiber-baserte papirark.
MX9603722A (es) Nuevos pseudopeptidos sustituidos con heterociclos.
NO902039L (no) Fremgangsmaate ved dyrking av cellekulturer i bioreaktor.
KR880007986U (ko) 메탄가스 발생용 정화조

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KROHER, STROBEL RECHTS- UND PATENTANWAELTE, 80336

8328 Change in the person/name/address of the agent

Representative=s name: DR. SCHOEN & PARTNER, 80336 MUENCHEN